or Try an Advanced Search...

    Cancer Vaccine Stocks List

    Symbol Grade Name % Change
    AGEN F Agenus Inc. -0.64
    MRNA F Moderna, Inc. -6.86
    EVAX F Evaxion Biotech A/S -4.58
    INDP F Indaptus Therapeutics, Inc. 0.00
    RENB D Renovaro Biosciences Inc. 12.47
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Cancer Biotechnology Clinical Medicine Medicine Vaccines Cancer Immunotherapy Immunotherapy Infectious Diseases Melanoma Non Small Cell Lung Cancer Vaccination Alzheimer's Disease Antibody Therapy Artificial Intelligence Bacterial Disease Biology Bladder Cancer Carcinoma Chemotherapy Coronavirus

    Related ETFs - A few ETFs which own one or more of the above listed Cancer Vaccine stocks.

    Symbol Grade Name Weight
    BBH D Market Vectors Biotech ETF 3.25
    FBT A First Trust Amex Biotech Index Fund 3.15
    IBBQ B Invesco Nasdaq Biotechnology ETF 2.13
    LGHT C Langar Global HealthTech ETF 2.12
    XBI A SPDR S&P Biotech ETF 2.01
    View all Cancer Vaccine ETFs...
    Compare ETFs
    Compare FBT to IBBQ Compare FBT to XBI Compare LGHT to XBI

        Cancer Vaccine Stocks Recent News

        Date Stock Title
        Nov 9 MRNA What Moved Markets This Week
        Nov 8 MRNA Moderna's Q3 Earnings Beat Overshadowed By Vaccine Demand Slowdown And Market Share Concerns, Analysts Warn
        Nov 8 MRNA 2 Biotech Stocks You Can Buy Hand Over Fist This Month
        Nov 8 MRNA Moderna (MRNA) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
        Nov 8 MRNA Moderna Receives Health Canada Approval for RSV Vaccine for Adults Aged 60 Years and Older
        Nov 8 MRNA Carisma Unveils Promising Pre-Clinical Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma
        Nov 8 MRNA Moderna Third Quarter 2024 Earnings: Beats Expectations
        Nov 8 MRNA Moderna Inc (MRNA) Q3 2024 Earnings Call Highlights: Strong Revenue and Strategic Growth Amidst ...
        Nov 7 MRNA Pfizer, GSK, Moderna struggle in a shrinking RSV vaccine market
        Nov 7 MRNA Moderna (MRNA) Q3 2024 Earnings Call Transcript
        Nov 7 MRNA Moderna Stock Rises on Q3 Earnings & Sales Beat, Reiterates View
        Nov 7 MRNA Moderna Stock Rises on Surprise Q3 Profit
        Nov 7 MRNA Moderna Gets Third-Quarter Boost From Early COVID-19 Shot Approval as Sales Top Street Views
        Nov 7 MRNA 2025 will be 'fairly challenging year' for Moderna: Analyst
        Nov 7 MRNA Ahead of Fed Decision, Big Earnings Wins for Forgotten Names
        Nov 7 AGEN Agenus to Present Compelling Data on Botensilimab and AGEN1721 at SITC 2024
        Nov 7 MRNA Moderna Sales Get Lift From Early Nod for Newest Covid Shot
        Nov 7 MRNA Moderna Surges After Crushing Sales Forecasts, Reiterating Its Outlook
        Nov 7 MRNA Moderna Stock Jumps on Better-Than-Expected Covid-19 Vaccine Sales
        Nov 7 MRNA Moderna, Inc. 2024 Q3 - Results - Earnings Call Presentation
        Related Industries: Biotechnology
        Related Stock Lists: Cancer Biotechnology Clinical Medicine Medicine Vaccines Cancer Immunotherapy Immunotherapy Infectious Diseases Melanoma Non Small Cell Lung Cancer Vaccination Alzheimer's Disease Antibody Therapy Artificial Intelligence Bacterial Disease Biology Bladder Cancer Carcinoma Chemotherapy Coronavirus
        Cancer Vaccine

        A cancer vaccine is a type of immunotherapy that uses a person’s own immune system to fight cancer. It works by stimulating the body’s natural defenses to recognize and attack cancer cells. Cancer vaccines are designed to target specific types of cancer, such as breast, lung, or prostate cancer. They may also be used to prevent cancer from developing in the first place.

        Browse All Tags